[1]
The Editorial Board of the Cancer Statistics in Japan, Takayama,S., Editor-in-chief. Cancer Statistics in Japan 2012; Foundation for Promotion of Cancer Research, National Cancer Center: Tokyo, 2012.
[2]
Langley, R.R.; Fidler, I.J. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr. Rev., 2007, 28, 297-321.
[3]
Nguyen, D.X.; Bos, P.D. Massagué, J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer, 2009, 9, 274-284.
[4]
Witz, I.P. The tumor microenvironment: the making of a paradigm. Cancer Microenviron., 2009, 2(1), 9-17.
[5]
Labelle, M.; Hynes, R.O. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov., 2012, 2, 1091-1099.
[6]
Kawaguchi, T. Cancer metastasis: characterization and identification of the behavior of metastatic tumor cells and the cell adhesion molecules, including carbohydrates. Curr. Drug Targets Cardiovasc. Haematol. Disord., 2005, 5, 39-64.
[7]
Kawaguchi, T.; Takazawa, H.; Imai, S.; Morimoto, J.; Watanabe, T.; Kanno, M.; Igarashi, S. Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical Muc1 bearing Tn antigen a receptor of VVA? Breast Cancer Res. Treat., 2006, 98, 31-43.
[8]
Suzuki, H.; Kawaguchi, T.; Hasegawa, T.; Yonechi, A.; Ohsugi, J.; Higuchi, M.; Yamada, F.; Shio, Y.; Fujiu, K.; Kanno, R.; Ohishi, A.; Gotoh, M. Prognostic impact of p53 protein overexpression in patients with node-negative lung adenocarcinoma. Cancer Lett., 2006, 237, 242-247.
[9]
Shio, Y.; Suzuki, H.; Kawaguchi, T.; Ohsugi, J.; Higuchi, M.; Fujiu, K.; Kanno, R.; Ohishi, A.; Gotoh, M. Carbohydrate status detecting by PNA is changeable through cancer prognosis from primary to metastatic nodal site: a possible prognostic factor in patient with node-positive lung adenocarcinoma. Lung Cancer, 2007, 57, 187-192.
[10]
Kawaguchi, T.; Imai, S.; Haga, S.; Morimoto, J.; Honda, T. Demonstration and Partial Identification of Aberrant MUC1 Bearing Tn Antigen in Rat Ascites Hepatoma AH109A Cells with Strong Lymph Node Metastasis Propensity. In: Cancer Metastasis Research; Watanabe, A., Ed.; Nova Science Publishers:Hauppauge, NY. , 2008; pp. 147-163.
[11]
Kawaguchi, T.; Honda, T.; Nishihara, M.; Yamamoto, T.; Yokoyama, M. Histological study on side effects and tumor targeting of a block copolymer micelle on rats. J. Control. Release, 2009, 136, 240-246.
[12]
Kawaguchi, T.; Kanno, M.; Asahi, S.; Honda, T. Relationship Between Carbohydrate Expression Profiles of Cancer Cells and Prognosis of Breast Cancer Patients. In: Aggressive Breast Cancer; DeFrina, R.H., Ed.; Nova Science Publishers: Hauppauge, NY, 2010; pp. 231-235.
[13]
Kawaguchi, T.; Kanno, M.; Takazawa, H.; Imai, S.; Morimoto, J.; Haga, S.; Honda, T. Lymphatic Spreading Propensity and Aberrant MUC1 Bearing TN/TN-like Carbohydrate of Aggressive Breast Cancer Cells. In: Aggressive Breast Cancer; DeFrina, R.H., Ed.; Nova Science Publishers: Hauppauge, NY, 2010; pp. 199-228.
[14]
Kawaguchi, T. Cancer Metastasis Research, Pathological Insight; Nova Science Publishers: Hauppauge, NY, 2012.
[15]
Willis, R.A. The Spread of Tumours in the Human Body, 3rd ed; Butterworths: London, 1973.
[16]
Paget, S. The distribution of secondary growths in cancer of the breast. Lancet, 1889, 133, 571-573.
[17]
Ewing, J. Neoplastic Disease: A Treatise on Tumours; W.B. Saunders: Philadelphia, 1928.
[18]
Walther, H.E. Krebsmetastasen; Benno Schwabe: Basel, 1948. (in German)
[19]
Viadana, E.; Bross, I.D.J.; Pickren, J.W. Cascade Spread of Blood-borne Metastases in Solid and Nonsolid Cancers of Humans. In: Pulmonary Metastasis; Weiss, L.; Gilbert, H.A., Eds.; Martinus Nijhoff Medical Division: The Hague, 1978; pp. 142-167.
[20]
Batson, O.V. The Vertebral Vein System: Caldwell Lecture, 1956. In: Bone Metastasis; Weiss, L.; Gilbert, H.A., Eds.; GK Hall: Boston, 1981; pp. 21-48.
[21]
de la Monte, S.M.; Moore, G.W.; Hutchins, G.M. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res., 1983, 43, 3427-3433.
[22]
Viadana, E.; Bross, I.D.J.; Pickren, J.W. The spread of blood-borne metastases in malignant lymphomas of man. Oncology, 1976, 33, 123-131.
[23]
Lee, Y-T.N. Breast carcinoma: pattern of metastasis at autopsy. J. Surg. Oncol., 1983, 23, 175-180.
[24]
Saitoh, H. Distant metastasis of renal adenocarcinoma. Cancer, 1981, 48, 1487-1491.
[25]
de la Monte, S.M.; Moore, G.W.; Hutchins, G.M. Nonrandom distribution of metastases in neuroblastic tumors. Cancer, 1983, 52, 915-925.
[26]
Abrams, H.L.; Spiro, R.; Goldstein, N. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer, 1950, 3, 74-85.
[27]
Mori, W.; Adachi, Y.; Okabe, H.; Oota, K. An analysis of 755 autopsied cases of malignant tumors: a statistical study of their metastasis. Jpn. J. Cancer Clin., 1963, 9, 351-374. [in Japanese].
[28]
Urano, Y.; Fukushima, T.; Kitamura, S.; Mori, H.; Baba, K.; Aizawa, S. Recent knowledge about cancer metastasis: cancer metastasis as observed in autopsy records. Oncologia, 1985, 15, 46-71. [in Japanese].
[29]
Sugarbaker, E.V. Patterns of metastasis in human malignancies. Cancer Biol. Rev., 1981, 2, 235-278.
[30]
Hart, I.R. ‘Seed and soil’ revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev., 1982, 1, 5-16.
[31]
Zetter, B.R. The cellular basis of site-specific tumor metastasis. N. Engl. J. Med., 1990, 322, 605-612.
[32]
Nicolson, G.L. Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis. Exp. Cell Res., 1993, 204, 171-180.
[33]
Dittmar, T.; Heyder, C.; Gloria-Maercker, E.; Hatzmann, W.; Zänker, K.S. Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin. Exp. Metastasis, 2008, 25, 11-32.
[34]
Talmadge, J.E.; Fidler, I.J. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res., 2010, 70, 5649-5669.
[35]
Kawaguchi, T.; Kawaguchi, M.; Miner, K.M.; Lembo, T.M.; Nicolson, G.L. Brain meninges tumor formation by in vivo-selected metastatic B16 melanoma variants in mice. Clin. Exp. Metastasis, 1983, 1, 247-259.
[36]
Kawaguchi, T.; Ikeda, K. Experimental studies on factors affecting tumor growth in the liver I. A scrutiny of number of cells and volume of fluid inoculated. Fukushima J. Med. Sci., 1976, 23, 11-16.
[37]
Sugino, T.; Kawaguchi, T. New metastatic tumor model using cancer cell nest from C3H mammary carcinoma. Nyugan Kiso Kenkyu, 1992, 2, 34-38. [in Japanese].
[38]
Sato, H.; Suzuki, M. Deformability and Viability of Tumor Cells by Transcapillary Passage, with Reference to Organ Affinity of Metastasis in Cancer. In: Fundamental Aspects of Metastasis; Weiss, L., Ed.; North-Holland: Amsterdam, 1976; pp. 311-317.
[39]
Suzuki, M. Studies on metastasis XXIV. Experiments on the brain metastasis of the rat ascites hepatoma cells. J. Tuberculosis and Leprosy, 1968, 20, 181-194. [in Japanese].
[40]
Asahina, S. Experimental studies on relationship between tumors and organs by direct transplantation of small number of cells of ascites tumor into tissues. Fukushima Igaku Zasshi, 1967, 17, 65-89. [in Japanese].
[41]
Kawaguchi, T.; Nakamura, K. Relationship between transcerebral passage of tumor cells and brain metastasis. Gann, 1977, 68, 65-71.
[42]
Warren, B.A. Arrest and extravasation of cancer cells with special reference to brain metastasis and microinjury hypothesis. In: Brain Metastasis; Weiss, L.; Gilbert, H.A.; Posner, J.B., Eds.; GK Hall: Boston, 1980; pp. 81-99.
[43]
Sato, H.; Suzuki, M. Experimental studies on metastasis formation, with special reference to the mechanism of cancer cell lodgement in the microcirculation.In: Atherogenesis. Vol. II, International
Congress Series No. 269, Proceedings of the Second International
Symposium on Atherogenesis, Thrombogenesis and Pyridinolcarbamate
Treatment, Shimamoto, T.; Numano, F.; Addison,
G.M., Eds.; Excerpta Medica: Amsterdam. 1973, pp. 168-176.
[44]
Endo, M. Effect of dead cell embolism on formation of haematogenous metastases in the brain. Fukushima Igaku Zasshi, 1980, 30, 189-203. [in Japanese].
[45]
Kobayashi, T.; Kitamura, H.; Tobai, S.; Asahina, S.; Nakamura, K. Experimental studies on hematogenous metastasis in the kidney (1): effect of ischemia. Fukushima Igaku Zasshi, 1980, 29, 247-257. [in Japanese].
[46]
Nakamura, K.; Suzuki, K. Quantitative study on the trans-pulmonary passage of tumor cells. Gann, 1969, 60, 483-497.
[47]
Sakurai, T.; Ebina, Y.; Yokoya, S.; Nakamura, K. Electron microscopic studies on extravasation of ascites hepatomas in the kidney and lung. Fukushima J. Med. Sci., 1977, 24, 1-21.
[48]
Ogiu, T.; Nakamura, K. Growth of intraperitoneally transplanted ascites hepatoma, AH39 cells, in the area of gelatin sponge inoculation into the abdominal wall of Donryu rats. Gann, 1979, 70, 173-179.
[49]
Kawaguchi, T.; Kitamura, H.; Nakamura, K. Tumor formation of rat ascites hepatoma cells in the traumatized brain. Gann, 1979, 70, 337-342.
[50]
Kawaguchi, T.; Endo, M.; Tobai, S.; Nakamura, K. Behavior pattern of rat ascites tumor cells arrested in liver sinusoids: an electron microscopic study. Gann, 1979, 70, 277-290.
[51]
Kawaguchi, T.; Tobai, S.; Nakamura, K. Extravascular migration of tumor cells in the brain: an electron microscopic study. Invasion Metastasis, 1982, 2, 40-50.
[52]
Nakashima, Y.; Kawaguchi, T.; Nakamura, K. The mechanisms of metastasis formation in injured parietal peritoneum by Yoshida sarcoma cells: an electron microscopic study. Fukushima J. Med. Sci., 1985, 31, 17-28.
[53]
Velnar, T.; Bailey, T.; Smarkolj, V. The wound healing process: an overview of the cellular and molecular mechanisms. J. Int. Med. Res., 2009, 37, 1528-1542.
[54]
French, J.E.; Macfarlane, R.G. Haemostasis and thrombosis.In:General Pathology, 4th ed; Florey, L., Ed.; Lloyd-Luke: London, 1970, pp. 273-317.
[55]
Wood, S., Jr Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. Arch. Pathol., 1958, 66, 550-568.
[56]
Chambers, A.F.; Groom, A.C.; MacDonald, I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer, 2002, 2, 563-572.
[57]
Krafts, K.P. Tissue repair: the hidden drama. Organogenesis, 2010, 6, 225-233.
[59]
Cox, T.R.; Bird, D.; Baker, A.M.; Barker, H.E.; Ho, M-W.Y.; Lang, G.; Erler, J.T. LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res., 2013, 73, 1721-1732.
[60]
Orr, F.W.; Warner, D.J. Effects of systemic complement activation and neutrophil-mediated pulmonary injury on the retention and metastasis of circulating cancer cells in mouse lungs. Lab. Invest., 1990, 62, 331-338.
[61]
Soares, F.A.; Shaughnessy, S.G.; MacLarkey, W.R.; Orr, F.W. Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo. Lab. Invest., 1994, 71, 480-489.
[62]
Dinarello, C.A. Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev., 2010, 29, 317-329.
[63]
Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 1985, 43, 175-203.
[64]
Dvorak, H.F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med., 1986, 315, 1650-1659.
[65]
Zeamari, S.; Roos, E.; Stewart, F.A. Tumour seeding in peritoneal wound sites in relation to growth-factor expression in early granulation tissues. Eur. J. Cancer, 2004, 40, 1431-1440.
[66]
Rudenstam, C.M. Experimental studies on trauma and metastasis formation. Acta Chir. Scand. Suppl., 1968, 391, 1-83.
[67]
Hofer, S.O.P.; Molema, G.; Hermens, R.A.E.C.; Wanebo, H.J.; Reichner, J.S.; Hoekstra, H.J. The effect of surgical wounding on tumour development. Eur. J. Surg. Oncol., 1999, 25, 231-243.
[68]
Murthy, S.M.; Goldschmidt, R.A.; Rao, L.N.; Ammirati, M.; Buchmann, T.; Scanlon, E.F. The influence of surgical trauma on experimental metastasis. Cancer, 1989, 64, 2035-2044.
[69]
DerHagopian, R.P.; Sugarbaker, E.V.; Ketcham, A. Inflammatory oncotaxis. JAMA, 1978, 240, 374-375.
[70]
Poste, G. Experimental systems for analysis of the malignant phenotype. Cancer Metastasis Rev., 1982, 1, 141-199.
[71]
Nicolson, G.L. Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochim. Biophys. Acta, 1988, 948, 175-224.
[72]
Matsuura, N.; Puzon-McLaughlin, W.; Irie, A.; Morikawa, Y.; Kakudo, K.; Takada, Y. Induction of experimental bone metastasis in mice by transfection of integrin α4β1 into tumor cells. Am. J. Pathol., 1996, 148, 55-61.
[73]
Yoshida, T. Comparative studies of ascites hepatomas. Methods in Cancer Res., 1971, 6, 97-157.
[74]
Odashima, S. Establishment of ascites hepatomas in the rat: 1951-1962. Natl. Cancer Inst. Monogr., 1964, 16, 51-93.
[75]
Sato, H. Experimental studies on the mechanism of metastasis formation. Acta Pathol. Jpn., 1959, 9, 685-706.
[76]
Sato, Y. Difference in Genome Between Rat Ascites Hepatoma AH7974 and AH7974F Cells Which Display Differential Liver
Metastatic Ability. PhD Thesis. No. 230, Fukushima Medical
University School of Medicine: Fukushima. 1997. (in Japanese)
[77]
Kawaguchi, T.; Endo, M.; Yokoya, S.; Nakamura, K. Influence of lodgement site on the proliferation-kinetics of tumor cells. Experientia, 1981, 37, 414-415.
[78]
Kawaguchi, T.; Endo, M.; Yokoya, S.; Nakamura, K. Difference in proliferation-kinetics between tumor cells arrested in the brain and liver. Experientia, 1982, 38, 1236-1237.
[79]
Kawaguchi, T.; Nakamura, K. Analysis of the lodgement and extravasation of tumor cells in experimental models of hematogenous metastasis. Cancer Metastasis Rev., 1986, 5, 77-94.
[80]
Kawaguchi, T.; Endo, M.; Tobai, S.; Nakamura, K. Behavior pattern of rat ascites tumor cells arrested in liver sinusoids: an electron microscopic study. Gann, 1979, 70, 277-290.
[81]
Paku, S.; Döme, B.; Tóth, R.; Timár, J. Organ-specificity of the extravasation process: an ultrastructural study. Clin. Exp. Metastasis, 2001, 18, 481-492.
[82]
Dingeman, K.P.; Roos, E.; van den Bergh Weerman, M.A.; van de Pavert, I.V. Invasion of liver tissue by tumor cells and leucocytes: comparative ultrastructure. J. Natl. Cancer Inst., 1978, 60, 583-598.
[83]
Shibue, T.; Brooks, M.W.; Inan, M.F.; Reinhardt, F.; Weinberg, R.A. The outgrowth of micrometastases is enabled by the formation of filopodium-like protrusions. Cancer Discov., 2012, 2, 706-721.
[84]
Watanabe, K. Experimental study on organ preference of cancer metastasis: establishment and characterization of highly metastatic sublines to eye ball derived from rat ascites hepatoma AH7974. Fukushima Igaku Zasshi, 1989, 39, 575-584. [in Japanese].
[85]
Saito, A. The development of useful experimental model for analysis of organ preference on cancer metastasis: the establishment of highly metastatic cell lines to rat ovary and their metastatic propensity. Fukushima Igaku Zasshi, 1989, 39, 585-595. [in Japanese].
[86]
Hoshi, N. Establishment of Highly Metastatic Subline Bo-4 from Rat Ascites Hepatoma AH7974., PhD Thesis, No. 200, Fukushima Medical
University School of Medicine: Fukushima,. 1995. (in Japanese)
[87]
Fidler, I.J. Selection of successive tumour lines for metastasis. Nat. New Biol., 1973, 242, 148-149.
[88]
Gaede, S.D.; Sholley, M.M.; Quattropani, S.L. Endothelial mitosis during the initial stages of corpus luteum neovascularization in the cycling adult rat. Am. J. Anat., 1985, 172, 173-180.
[89]
Brunson, K.W.; Nicolson, G.L. Selection of malignant melanoma variant cell lines for ovary colonization. J. Supramol. Struct., 1979, 11, 517-528.
[90]
Ferry, A.P.; Font, R.L. Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases. Arch. Ophthalmol., 92, 276-286. 1974
[91]
Young, R.H. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the Krukenberg tumor. Adv. Anat. Pathol., 2006, 13, 205-227.
[92]
Kawaguchi, T.; Saito, A. Pathology of organ preference metastasis. Mebio, 1992, 7, 22-30. [in Japanese].
[93]
Kizuka, F.; Tokuda, N.; Takagi, K.; Adachi, Y.; Lee, L.; Tamura, I.; Maekawa, R.; Taketani, T.; Tamura, H.; Suzuki, T.; Owada, Y.; Sugino, N. Involvement of bone marrow-derived vascular progenitor cells in neovascularization during formation of the corpus luteum in mice. Biol. Reprod., 2012, 87, 1-7.
[94]
Fidler, I.J.; Kripke, M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science, 1977, 197, 893-895.
[95]
Nicolson, G.L. Tumor and host molecules important in the organ preference of metastasis. Semin. Cancer Biol., 1991, 2, 143-154.
[96]
Brunson, K.W.; Beattie, G.; Nicolson, G.L. Selection and altered properties of brain-colonising metastatic melanoma. Nature, 1978, 272, 543-545.
[97]
Miner, K.M.; Kawaguchi, T.; Uba, G.W.; Nicolson, G.L. Clonal drift of cell surface, melanogenic, and experimental metastatic properties of in vivo-selected, brain meninges-colonizing murine B16 melanoma. Cancer Res., 1982, 42, 4631-4638.
[98]
Irimura, T.; Nicolson, G.L. Carbohydrate chain analysis by lectin binding to electrophoretically separated glycoproteins from murine B16 melanoma sublines of various metastatic properties. Cancer Res., 1984, 44, 791-798.
[99]
Nicolson, G.L.; Dulski, K.; Basson, C.; Welch, D.R. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties. Invasion Metastasis, 1985, 5, 144-158.
[100]
Nicolson, G.L.; Van Pelt, C.; Irimura, T.; Kawaguchi, T. Stabilities and characteristics of brain meninges-colonizing murine melanoma cells. Prog. Exp. Tumor Res., 1985, 29, 17-35.
[101]
Nicolson, G.L.; Kawaguchi, T.; Kawaguchi, M.; Van Pelt, C. Brain surface invasion and metastasis of murine malignant melanoma variants. J. Neurooncol., 1987, 4, 209-218.
[102]
Nicolson, G.L.; Inoue, T.; Van Pelt, C.S.; Cavanaugh, P.G. Differential expression of a Mr~90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization. Cancer Res., 1990, 50, 515-520.
[103]
Marchetti, D.; Menter, D.; Jin, L.; Nakajima, M.; Nicolson, G.L. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int. J. Cancer, 1993, 55, 692-699.
[104]
Kawaguchi, T.; Kawaguchi, M.; Miner, K.M.; Lembo, T.M.; Nicolson, G.L. Brain meninges tumor formation by in vivo-selected metastatic B16 melanoma variants in mice. Clin. Exp. Metastasis, 1983, 1, 247-259.
[105]
Kawaguchi, T.; Kawaguchi, M.; Dulski, K.M.; Nicolson, G.L. Cellular behavior of metastatic B16 melanoma in experimental blood-borne implantation and cerebral invasion: an electron microscopic study. Invasion Metastasis, 1985, 5, 16-30.
[106]
Kawaguchi, T.; Kawaguchi, M.; Lembo, T.M.; Nicolson, G.L. Differential tumor growth of blood-borne B16 melanoma variants in cerebral dura mater is related to tumor-host cell reactions. Clin. Exp. Metastasis, 1989, 7, 1-14.
[107]
Benton, R.L.; Maddie, M.A.; Minnillo, D.R.; Hagg, T.; Whittemore, S.R. Griffonia simplicifolia isolectin B4 identifies a specific subpopulation of angiogenic blood vessels following contusive spinal cord injury in the adult mouse. J. Comp. Neurol., 2008, 507, 1031-1052.
[108]
Barden, H.; Levine, S. Histochemical observations on rodent brain melanin. Brain Res. Bull., 1983, 10, 847-851.
[109]
Brouland, J.P.; Megarbane, B.; Kafe, H.; Brouet, J.C.; Mikol, J. Cerebro-meningeal localization of extramedullary haematopoiesis (EMH), a rare complication of chronic idiopathic myelofibrosis (CIM). Neuropathol. Appl. Neurobiol., 2004, 30, 396-401.
[110]
Yamamura, H.; Sato, H. Quantitative studies on the developing vascular system of rat hepatoma. J. Natl. Cancer Inst., 1974, 53, 1229-1240.
[111]
Hori, K.; Suzuki, M.; Tanda, S.; Saito, S. In vivo analysis of tumor vascularization in the rat. Jpn. J. Cancer Res., 1990, 81, 279-288.
[112]
Miura, Y.; Ariga, M.; Miyauchi, M.; Arai, K.; Yagasaki, K. Isolation and characterization of subpopulations of rat ascites hepatoma cell line of AH109A with different metastatic potentials. Cytotechnology, 2003, 43, 27-32.
[113]
Hiratsuka, S.; Nakamura, K.; Iwai, S.; Murakami, M.; Itoh, T.; Kijima, H.; Shipley, J.M.; Senior, R.M.; Shibuya, M. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell, 2002, 2, 289-300.
[114]
World Health Organization Classification of Tumours, Pathology
and Genetics of Tumours of the lung, pleura, thymus and heart.
Travis, W.D.; Brambilla, E.; Müller-Hermelink, H.K.; Harris, C.C.,
Eds.; IARC Press: Lyon,; , 2004.
[115]
Smid, M.; Wang, Y.; Zhang, Y.; Sieuwerts, A.M.; Yu, J.; Klijn, J.G.; Foekens, J.A.; Martens, J.W. Subtypes of breast cancer show preferential site of relapse. Cancer Res., 2008, 68, 3108-3114.
[116]
Liotta, L.A. Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res., 1986, 46, 1-7.
[117]
Tanjore, H.; Kalluri, R. The role of type IV collagen and basement membranes in cancer progression and metastasis. Am. J. Pathol., 2006, 168, 715-717.
[118]
Nicolson, G.L. Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev., 1988, 7, 143-188.
[119]
Klein, E. Gradual transformation of solid into ascites tumors: evidence favoring the mutation-selection theory. Exp. Cell Res., 1955, 8, 188-212.
[120]
Yoshida, T. Contributions of the ascites hepatoma to the concept of malignancy of cancer. Ann. N. Y. Acad. Sci., 1956, 63, 852-881.
[121]
Raz, A.; Ben-Ze’ev, A. A modulation of the metastatic capability in B16 melanoma by cell shape. Science, 1983, 221, 1307-1310.
[122]
Kawaguchi, T.; Igarashi, S.; Wakabayashi, H.; Yokoya, S.; Fukui, K. Substrate adhesiveness and experimental metastatic potential of rat ascites hepatoma AH7974-derived variant sublines. Clin. Exp. Metastasis, 1992, 10, 225-238.
[123]
Kawaguchi, T.; Ono, T.; Wakabayashi, H.; Igarashi, S. Cell surface laminin-like substances and laminin-related carbohydrates of rat ascites hepatoma AH7974 and its variants with different lung-colonizing potential. Clin. Exp. Metastasis, 1994, 12, 203-212.
[124]
Kawaguchi, T.; Watanabe, K.; Sugino, T.; Sakuma, A.; Igarashi, S.; Ono, T.; Nakamura, K.; Kimura, A.; Yokoya, S.; Ozawa, M.; Muramatsu, T. Establishment and Characterization of Metastatic Ascites Hepatoma Variants with Different Adhesive Properties to Substrate in vitro. In: Recent Progress of Life Science Technology in Japan; Ikawa, Y.; Wada, A., Eds.; Academic Press: Tokyo, 1989; pp. 267-279.
[125]
Murray, J.C.; Liotta, L.; Rennard, S.I.; Martin, G.R. Adhesion characteristics of murine metastatic and nonmetastatic tumor cells in vitro. Cancer Res., 1980, 40, 347-351.
[126]
Bal de Kier Joffé, E.; Puricelli, L.; de Lustig, E.S. Modified adhesion behavior after in vitro passage of two related murine mammary adenocarcinomas with different metastasizing ability. Invasion Metastasis, 1986, 6, 302-312.
[127]
Terranova, V.P.; Liotta, L.A.; Russo, R.G.; Martin, G.R. Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res., 1982, 42, 2265-2269.
[128]
Kimura, A.; Kawaguchi, T.; Ono, T.; Sakuma, A.; Yokoya, Y.; Kochi, H.; Nakamura, K. Cell surface heparan sulphate and adhesive property of sublines of rat ascites hepatoma AH7974. J. Cell Sci., 1988, 90, 683-689.
[129]
Sanderson, R.D. Heparan sulfate proteoglycans in invasion and metastasis. Semin. Cell Dev. Biol., 2001, 12, 89-98.
[130]
Nakajima, M.; Irimura, T.; Di Ferrante, N.; Nicolson, G.L. Heparan sulphate degradation: relation to tumor invasive and metastatic properties of tumor cells of mouse B16 melanoma sublines. Science, 1983, 220, 611-613.
[131]
Ozawa, M.; Sato, M.; Muramatsu, H.; Hamada, H.; Muramatsu, T. A membrane glycoprotein involved in teratocarcinoma cell adhesion to substratum. Exp. Cell Res., 1985, 158, 127-143.
[132]
Rieber, M.; Castillo, M.A.; Rieber, M.S.; Irwin, J.C.; Urbina, C. Decrease in tumor-cell attachment and in a 140-kDa fibronectin receptor correlate with greater expression of multiple 34-kDa surface proteins and cytoplasmic 54-kDa components. Int. J. Cancer, 1988, 41, 96-100.
[133]
Blumenstock, F.A.; Saba, T.M.; Weber, P.; Laffin, R. Biochemical and immunological characterization of human opsonic alpha2SB glycoprotein: its identity with cold-insoluble globulin. J. Biol. Chem., 1978, 253, 4287-4291.
[134]
Varani, J.; Lovett, E.J., III; Wicha, M.; Malinoff, H.; McCoy, J.P., Jr Cell surface α-D-galactopyranosyl end groups: use as markers in the isolation of murine tumor cell lines with different cancer-causing potentials. J. Natl. Cancer Inst., 1983, 71, 1281-1287.
[135]
Kawaguchi, T.; Kanno, M.; Kimijima, I.; Abe, R. Carbohydrate expression of tumor cells and prognosis of breast cancer-analysis on human cancer and experimental certification on mechanism. Basic Invest. Breast Carcinoma, 1997, 6, 41-47. [in Japanese].
[136]
Grimstad, I.A.; Varani, J.; McCoy, J.P., Jr Contribution of α-D-galacopyranoside end groups to attachment of highly and low metastatic murine fibrosarcoma cells to various substrates. Exp. Cell Res., 1984, 155, 345-358.
[137]
Hiserodt, J.C.; Laybourn, K.A.; Varani, J. Laminin inhibits the recognition of tumor target cells by murine natural killer (NK) and natural cytotoxic (NC) lymphocytes. Am. J. Pathol., 1985, 121, 148-155.
[138]
Castronovo, V.; Colin, C.; Claysmith, A.P.; Chen, P.H.; Lifrange, E.; Lambotte, R.; Krutzsc, J.; Liotta, L.A.; Sobel, M.E. Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. Am. J. Pathol., 1990, 137, 1373-1381.
[139]
Galili, U.; Macher, B.A. Interaction between anti-Gal and human tumor cells: a natural defense mechanism? J. Natl. Cancer Inst., 1989, 81, 178-179.
[140]
Ooishi, M.; Kawaguchi, T.; Hoshi, K.; Morimura, Y.; Sato, A.; Suzuki, T. Immunohistochemical demonstration of laminin in endometrial cancer of uterus in relation to it’s invasion and metastasis. Acta Obstet. Gynaecol. Jpn., 1995, 47, 955-956. [in Japanese].
[141]
Hakomori, S. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv. Cancer Res., 1989, 52, 257-331.
[142]
Irimura, T.; Nakamori, S.; Matsushita, Y.; Taniuchi, Y.; Todoroki, N.; Tsuji, T.; Izumi, Y.; Kawamura, Y.; Hoff, S.D.; Cleary, K.R. Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-Lex antigens. Semin. Cancer Biol., 1993, 4, 319-324.
[143]
Kannagi, R. Carbohydrate antigen sialyl Lewis a—its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med. J., 2007, 30, 189-209.
[144]
Springer, G.F. T and Tn, general carcinoma autoantigens. Science, 1984, 224, 1198-1206.
[145]
Dabelsteen, E. Cell surface carbohydrates as prognostic markers in human carcinomas. J. Pathol., 1996, 179, 358-369.
[146]
Brooks, S.A. The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. Histol. Histopathol., 2000, 15, 143-158.
[147]
Dennis, J.W.; Laferté, S.; Waghorne, C.; Breitman, M.L.; Kerbel, R.S. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science, 1987, 236, 582-585.
[148]
Kawaguchi, T.; Takano, Y.; Ohori, T.; Ito, F.; Koyama, S.; Kanno, T. Carbohydrate expression of cancer cells in progression of gastric cancer from early to advanced stage. Stomach and Intestine, 1997, 32, 797-808. [in Japanese].
[149]
Koyama, S.; Terashima, S.; Takano, Y.; Ohori, T.; Inoue, H.; Motoki, R.; Kawaguchi, T. P53 protein expression of carcinoma cells associated with metastasis and prognosis in gastric carcinomas: a clinicopathological study. Fukushima Igaku Zasshi, 1997, 47, 131-142. [in Japanese].
[150]
Terashima, S.; Takano, Y.; Ohori, T.; Kanno, T.; Kimura, T.; Motoki, R.; Kawaguchi, T. Soybean agglutinin binding as a useful prognostic indicator in stomach cancer. Surg. Today, 1997, 27, 293-297.
[151]
Terashima, S.; Takano, Y.; Ohori, T.; Kanno, T.; Kimura, T.; Motoki, R.; Kawaguchi, T. Sialyl-Tn antigen as a useful predictor of poor prognosis in patients with advanced stomach cancer. Surg. Today, 1998, 28, 682-686.
[152]
Ohori, T.; Kawaguchi, T. Carbohydrate expression of carcinoma cells associated with metastasis and prognosis in advanced gastric carcinomas: a clinicopathological study. Fukushima Igaku Zasshi, 1998, 48, 25-36. [in Japanese].
[153]
Takano, Y.; Teranishi, Y.; Terashima, S.; Motoki, R.; Kawaguchi, T. Lymph node metastasis-related carbohydrate epitopes of gastric cancer with submucosal invasion. Surg. Today, 2000, 30, 1073-1082.
[154]
Kanno, T. The Study on Correlation of Mucin Core Expression of Cancer Cells and Metastasis/Prognosis of Gastric Cancer. PhD
Thesis, No. 1014, Fukushima Medical University School of
Medicine: Fukushima. 1997. (in Japanese)
[155]
Itoh, F. The Study on Correlation of Blood Group Antigen ABH
Expression and Metastasis/Prognosis of Gastric Cancer.. PhD
Thesis, No.963, Fukushima Medical University School of
Medicine: Fukushima. 1996. (in Japanese)
[156]
Konno, A.; Hoshino, Y.; Terashima, S.; Motoki, R.; Kawaguchi, T. Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin. Exp. Metastasis, 2002, 19, 61-70.
[157]
Kimura, T. Clinicopathological Study on Relationship Between
ABH Antigen Expression of Cancer Cells and Metastasis/Prognosis
of Colorectal Cancer..PhD Thesis, No. 1015, Fukushima Medical University School of Medicine: Fukushima. 1997. (in Japanese)
[158]
Patton, S.; Gendler, S.J.; Spicer, A.P. The epithelial mucin, MUC1, of milk, mammary gland and other tissues. Biochim. Biophys. Acta, 1995, 1241, 407-423.
[159]
Kawaguchi, T.; Takazawa, H.; Imai, S.; Morimoto, J.; Watanabe, T. Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women. Breast Cancer Res. Treat., 2005, 92, 223-230.
[160]
Tsuchiya, A.; Kanno, M.; Kawaguchi, T.; Endo, Y.; Zhang, G.J.; Ohtake, T.; Kimijima, I. Prognostic relevance of Tn expression in breast cancer. Breast Cancer, 1999, 6, 175-180.
[161]
Kawaguchi, T. Liver Metastatic Breast Cancer Cells Express
Atypical MUC1 with Vicia villosa Agglutinin-Binding
Carbohydrate(s), Proceedings of the 95th Annual Meeting of the
American Association of Cancer Research, March 2004; AACR:
Orlando, FL,. 2004, 45, p. 52.
[162]
Holdsworth, P.J.; Thorogood, J.; Benson, E.A.; Clayden, A.D. Blood group as a prognostic indicator in breast cancer. Br. Med. J., 1985, 290, 671-773.
[163]
Lee, J.S.; Ro, J.Y.; Sahin, A.A.; Hong, W.K.; Brown, B.W.; Mountain, C.F.; Hittelman, W.N. Expression of blood-group antigen A—a favorable prognostic factor in non-small-cell lung cancer. N. Engl. J. Med., 1991, 324, 1084-1090.
[164]
Goldstein, I.J.; Blake, D.A.; Ebisu, S.; Williams, T.J.; Murphy, L.A. Carbohydrate binding studies on the Bandeiraea simplicifolia I isolectins. Lectins which are mono-, di-, tri-, and tetravalent for N-acetyl-D-galactosamine. J. Biol. Chem., 1981, 256, 3890-3893.
[165]
Hedlund, M.; Ng, E.; Varki, A.; Varki, N.M. α2-6-Linked sialic acids on N-glycans modulate carcinoma differentiation in vivo. Cancer Res., 2008, 68, 388-394.
[166]
Tuboi, S. Tumor defense systems using O-glycans. Biol. Pharm. Bull., 2012, 35, 1633-1636.
[167]
Madsen, C.B.; Lavrsen, K.; Steentoft, C.; Vester-Christensen, M.B.; Clausen, H.; Wandall, H.H.; Pedersen, A.E. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing. PLoS One, 2013, 8e72413
[168]
Fujita-Yamaguchi, Y. Renewed interest in basic and applied research involving monoclonal antibodies against an oncofetal Tn-antigen. J. Biochem., 2013, 154, 103-105.
[169]
Welinder, C.; Baldetorp, B.; Blixt, O.; Grabau, D.; Jansson, B. Primary breast cancer tumours contain high amounts of IgA1 immunoglobulin: an immunohistochemical analysis of a possible carrier of the tumour-associated Tn antigen. PLoS One, 2013, 8e61749
[170]
Danussi, C.; Coslovi, A.; Campa, C.; Mucignat, M.T.; Spessotto, P.; Uggeri, F.; Paoletti, S.; Colombatti, A. A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction. Glycobiology, 2009, 19, 1056-1067.
